BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30

• Business

  Danaher Appoints Martin Stumpe to New Role of Chief Data & Artificial Intelligence Officer

  Danaher Corporation today announced the creation of the new role of Chief Data & Artificial Intelligence Officer.

  June 5, 2024

   · 

  3 min read
• World’s First Wearable Ultrasound Patch in use for sepsis care at a Toronto Hospital

  FloPatch, a wearable ultrasound device, is in use in two critical care units at St. Michael’s Hospital.

  June 5, 2024

   · 

  2 min read
• Business

  Carrick Therapeutics Establishes New Headquarters in Boston, Massachusetts and Appoints David Sutherland, CPA, as Vice President of Finance and Controller

  Carrick Therapeutics Inc. today announced the relocation of its corporate headquarters from Dublin, Ireland to Boston, Massachusetts.

  June 5, 2024

   · 

  2 min read
• Nanox Launches Artificial Intelligence Functionality in Second Opinions Platform

  NANO-X IMAGING LTD announced that its deep-learning medical imaging analytics subsidiary, Nanox AI Ltd., has launched an artificial intelligence functionality in the Second Opinions online medical consultation service.

  June 5, 2024

   · 

  4 min read
• Biotech Bay

  Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024

  Assembly Biosciences, Inc. today announced new data for ABI-6250, the company’s orally bioavailable, small molecule hepatitis D virus (HDV) entry inhibitor candidate, featured in a poster presentation.

  June 5, 2024

   · 

  5 min read
• Genetown

  Inhibikase Therapeutics Announces Expansion to its Therapeutic Pipeline and Updates its Research and Development Programs

  Inhibikase Therapeutics, Inc. today announced expansion of its therapeutic pipeline and multiple updates to its Research and Development programs.

  June 5, 2024

   · 

  6 min read
• Biotech Beach

  Arcutis Announces Multiple Abstracts, Including Oral Presentation, Accepted at the Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference

  Arcutis Biotherapeutics, Inc. today announced that five abstracts will be presented at the Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference, which will take place in Chicago, IL from June 8-10, 2024.

  June 5, 2024

   · 

  5 min read
• Pharm Country

  Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast

  Annovis Bio Inc. today announced that it will host an investor webcast to discuss recent developments and future plans for its lead drug candidate, Buntanetap.

  June 5, 2024

   · 

  2 min read